These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37265189)

  • 21. Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma.
    Toyama T; Nitta N; Ohta S; Tanaka T; Nagatani Y; Takahashi M; Murata K; Shiomi H; Naka S; Kurumi Y; Tani T; Tabata Y
    Jpn J Radiol; 2012 Jan; 30(1):62-8. PubMed ID: 22194039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Imaging Biomarkers for
    Schobert I; Chapiro J; Nezami N; Hamm CA; Gebauer B; Lin M; Pollak J; Saperstein L; Schlachter T; Savic LJ
    J Nucl Med; 2019 Aug; 60(8):1066-1072. PubMed ID: 30655331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary evaluation of indigenous
    Subramanian S; Pandey U; Chaudhari P; Tyagi M; Gupta S; Singh G; Dash A; Samuel G; Venkatesh M
    Indian J Med Res; 2016 May; 143(Supplement):S74-S81. PubMed ID: 27748281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
    Herzer K; Müller S; Antoch G; Hilgard P
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preparation and biological characteristics of a new doxorubicin-gelatin-microspheres for hepatic artery embolization].
    Wan Y; Ma Y; Chen XL; Duan LG; Luo DH; Xia CQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):119-24. PubMed ID: 21355316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated use of
    Filippi L; Evangelista L; Schillaci O
    Expert Rev Gastroenterol Hepatol; 2023; 17(6):531-538. PubMed ID: 37194803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib.
    Teyateeti A; Mahvash A; Long J; Abdelsalam M; Avritscher R; Kaseb A; Odisio B; Ravizzini G; Surasi D; Teyateeti A; Macapinlac H; Kappadath SC
    World J Gastroenterol; 2021 Dec; 27(47):8166-8181. PubMed ID: 35068861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioembolization for the treatment of hepatocellular carcinoma.
    Kim HC
    Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives.
    Sacco R; Mismas V; Marceglia S; Romano A; Giacomelli L; Bertini M; Federici G; Metrangolo S; Parisi G; Tumino E; Bresci G; Corti A; Tredici M; Piccinno M; Giorgi L; Bartolozzi C; Bargellini I
    World J Gastroenterol; 2015 Jun; 21(21):6518-25. PubMed ID: 26074690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving Role of Radiopharmaceuticals in Hepatocellular Carcinoma Treatment.
    Wu L; Shen F; Xia Y; Yang YF
    Anticancer Agents Med Chem; 2016; 16(9):1155-65. PubMed ID: 26961314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC.
    Nam JY; Lee YB; Lee JH; Yu SJ; Kim HC; Chung JW; Yoon JH; Kim YJ
    Dig Dis Sci; 2022 Jan; 67(1):329-336. PubMed ID: 33538921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and physicochemical characterization of a biodegradable microspheres formulation loaded with samarium-153 and doxorubicin for chemo-radioembolization of liver tumours.
    Alregib AH; Tan HY; Wong YH; Kasbollah A; Wong EH; Abdullah BJJ; Perkins AC; Yeong CH
    J Labelled Comp Radiopharm; 2023 Aug; 66(10):308-320. PubMed ID: 37287213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy.
    Wang XM; Yin ZY; Yu RX; Peng YY; Liu PG; Wu GY
    World J Gastroenterol; 2008 Jan; 14(4):518-23. PubMed ID: 18203282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
    Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
    Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
    J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT.
    O'Connor PJ; Pasik SD; van der Bom IM; Bishay V; Radaelli A; Kim E
    Cardiovasc Intervent Radiol; 2020 Feb; 43(2):295-301. PubMed ID: 31578635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study.
    Kolligs F; Arnold D; Golfieri R; Pech M; Peynircioglu B; Pfammatter T; Ronot M; Sangro B; Schaefer N; Maleux G; Munneke G; Pereira H; Zeka B; de Jong N; Helmberger T;
    JHEP Rep; 2023 Feb; 5(2):100633. PubMed ID: 36593888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.